SCRN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.944400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.028000E-01
Normal-vs-Stage2
6.825600E-01
Normal-vs-Stage3
1.232590E-01
Normal-vs-Stage4
1.744840E-01
Stage1-vs-Stage2
1.509580E-01
Stage1-vs-Stage3
3.168500E-02
Stage1-vs-Stage4
2.195200E-01
Stage2-vs-Stage3
1.51330004083405E-09
Stage2-vs-Stage4
1.762710E-03
Stage3-vs-Stage4
4.650300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.866600E-01
Normal-vs-AfricanAmerican
8.618600E-01
Normal-vs-Asian
8.194200E-01
Caucasian-vs-AfricanAmerican
9.911400E-01
Caucasian-vs-Asian
8.627200E-01
AfricanAmerican-vs-Asian
8.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.215800E-01
Normal-vs-Female
9.166800E-01
Male-vs-Female
8.144300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.977600E-01
Normal-vs-Age(41-60Yrs)
8.524000E-01
Normal-vs-Age(61-80Yrs)
8.536200E-01
Normal-vs-Age(81-100Yrs)
3.378800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.168400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.506600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.297400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.741990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.472300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.853200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.851600E-01
Normal-vs-Daily Drinker
2.151000E-01
Normal-vs-Weekly Drinker
7.143800E-01
Normal-vs-Occasional Drinker
6.486800E-01
Normal-vs-Social Drinker
9.126200E-01
Non Drinker-vs-Daily Drinker
7.604000E-01
Non Drinker-vs-Weekly Drinker
5.453600E-01
Non Drinker-vs-Occasional Drinker
1.038430E-01
Non Drinker-vs-Social Drinker
1.190590E-01
Daily Drinker-vs-Weekly Drinker
3.242000E-01
Daily Drinker-vs-Occasional Drinker
8.275800E-02
Daily Drinker-vs-Social Drinker
2.535600E-02
Weekly Drinker-vs-Occasional Drinker
1.803040E-01
Weekly Drinker-vs-Social Drinker
4.089200E-01
Occasional Drinker-vs-Social Drinker
3.112600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.269200E-01
Normal-vs-Grade 2
2.303600E-02
Normal-vs-Grade 3
4.615600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.492200E-01
Grade 1-vs-Grade 3
7.902400E-01
Grade 1-vs-Grade 4
3.269200E-01
Grade 2-vs-Grade 3
9.120000E-01
Grade 2-vs-Grade 4
2.303600E-02
Grade 3-vs-Grade 4
4.615600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.324200E-01
Normal-vs-NonDiabetic
9.161600E-01
Diabetic-vs-NonDiabetic
1.531970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.057400E-01
Normal-vs-NoPancreatitis
8.753800E-01
Pancreatitis-vs-NoPancreatitis
3.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.562400E-01
Normal-vs-N1
7.447800E-01
N0-vs-N1
4.249200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.004000E-01
Normal-vs-TP53-NonMutant
8.567800E-01
TP53-Mutant-vs-TP53-NonMutant
7.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
